London Bridges Bike Ride
19 Aug 2018

Amo's London Bridges Cycle Ride 2

profile picture
Jodh Basra

Total raised


+ £82.75 Gift Aid

107 Complete
107% of £500.00 target

Donating through this page is simple, fast and totally secure. Your details are safe with Cancer Research UK

I’m raising as much as I can to beat cancer in memory of a friend

In memory of

Jake Whiteside

Hey everyone,
I am taking part in Amo's London Bridges Cycle Ride 2. We're all taking part for different reasons, and here is mine.

Jake Whiteside was a close friend of mine (one of the funniest I might add), and in April of 2017, he passed away from Brain Cancer. Even with his condition, Jake never failed to make us laugh, roast us, and will always be our dear friend. The ride itself marks 16 Months since Jake passed away. The ride starts at Chiswick Park on Sunday 19th Aug 18 and finishes at Mala Restaurant in St Katherines Dock.

Thank you for visiting my page, and thank you so much for your donations and support.

Latest updates


Sunny & Sharon Karir



+£2.50 Gift Aid

Good luck guys. Well done


Marissa Graysmark-Allen



+£2.50 Gift Aid

What a great thing to do Jodh. Good luck. Marissa and Holly x


Emily Potts



Gooodd luckkkk x


Connie Saunders



+£1.25 Gift Aid

Good luck!! X


Anita Kaur



Good luck jodh, you can do it brov,
All the best from Taran Johal.


Charley Went



+£2.50 Gift Aid

How lovely of you. Good luck xxx

Total raised£536.00



With Cancer Research UK Giving Pages more of the money raised goes towards beating cancer sooner. Aside from the credit and debit card fees, every penny donated goes to Cancer Research UK.

All donations made to this page will automatically be transferred to Cancer Research UK.


Brain cancer

Each year in the UK, more than 9,400 people are diagnosed with tumours that start in the brain or elsewhere in the central nervous system. With more than 100 different types of brain tumour, donations can help Cancer Research UK find out what causes them and develop better treatments to improve the outlook for patients.